Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-inflammatory diclofenac to decrease suicidality in recent suicide attempters with depressive disorder
2010-021024-10Phase 2Active
- Sponsor
- Organisation name was not entered
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of diclofenac in major depressive disorder (MDD) and Suicidality, sponsored by Organisation name was not entered. Primary endpoint: Change in suicidality. Started Feb 2011; status: active.
02
Drugs
diclofenac
03
Conditions
major depressive disorder (MDD)Suicidality
Beyond the preview
Go deeper on 2010-021024-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021024-10.